Arcus Biosciences announced that the Food and Drug Administration has granted its pancreatic cancer treatment, quemliclustat, with an orphan drug designation. The company said it expects its ongoing ...

The composition of the gut microbiome appears to be associated with treatment response in patients with pancreatic cancer, research suggests.

The Pancreatic Cancer Action Network (PanCAN), the leading nonprofit organization dedicated to [...] READ MORE ...

Jade Dorrian told the Irish News about pursuing her academic dreams after years of hiding from bullies at school.

Medicare Advantage enrollment was linked to poorer cancer survival despite similar adherence to treatment guidelines.

The latest research published in Genes & Diseases unveils groundbreaking insights into the role of the aging process and the ...

Trump administration policy tug-of-war between big medical groups that want COVID vaccines back on CDC schedule for healthy ...

Dana-Farber experts report rising rates of colorectal, pancreatic, esophageal, and other less common GI cancers in people under 50 and point to ...

PURPOSEGEMPAX was an open-label, randomized phase III clinical trial designed to assess the efficacy and tolerability of gemcitabine plus paclitaxel versus gemcitabine alone as second-line treatment ...

Experts have revealed the surprising reason why an increasing number of young adults are now found to be suffering from colon ...